Second Look Laparoscopy in Colorectal Cancer (NCT01628211) | Clinical Trial Compass
UnknownPhase 2
Second Look Laparoscopy in Colorectal Cancer
Italy140 participantsStarted 2012-04
Plain-language summary
The purpose of this study is to evaluate whether a second-look laparoscopy, followed by peritonectomy, hyperthermic intraperitoneal chemotherapy (HIPEC) or systemic chemotherapy in case of peritoneal carcinosis, improves the overall survival of patients who have had radical resection of mucinous colorectal cancer.
Who can participate
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Histologic diagnosis colorectal adenocarcinoma
* Mucinous histotype
* Stage I-III
* Radical (R0) surgical resection of primary tumor
* CT scan with contrast showing no evidence of disease recurrence 6 months after primary surgery
* Age ≥ 18 ≤ 65 years
* Performance Status ECOG ≤1
* Normal hepatic, renal and hematologic function
* Adjuvant chemotherapy permitted
* Signed informed consent
Exclusion Criteria:
* Residual disease after surgical resection of primary tumor
* Distant metastasis
* Active systemic infection
* Chronic cardiovascular illness that would contraindicate abdominal dilatation with pneumoperitoneum
* Concomitant or previous malignancy with 5 years of surgical resection of primary tumor (except for adequately treated non-melanoma skin cancer and in situ cervical cancer)
* Pregnancy or lactation
* Refusal or incapability of providing informed consent
* Impossibility of complying with study schedules and follow-up
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.